BioCentury | Jun 11, 2007
Company News

Cambria BioSciences LLC, Pfizer deal

...antiparasitic drug candidates from PFE's Pfizer Animal Health subsidiary. Cambria is eligible for undisclosed milestones. Cambria...
BioCentury | May 18, 2007
Clinical News

Cambria unveils epilepsy program

...Neurology company Cambria (Woburn, Mass.) presented a high throughput in vivo Drosophila model of epilepsy at...
...platform uses fruit flies treated with neurotoxins to screen for compounds that produce anti-epileptic effects. Cambria...
BioCentury | Jan 23, 2007
Financial News

Bionovo raises $15.7 million

...$3.20 on Friday. Investors included RA Capital; Paramount BioCapital; BioCapital Asset Management; and Ironwood Capital. Cambria...
BioCentury | Dec 20, 2004
Company News

Cambria BioSciences LLC, The Dow Chemical Co. deal

...Under a 2002 deal to develop neuroactive insecticides, Cambria received undisclosed milestone payments from DOW subsidiary...
...The milestones were triggered by Cambria validating targets and developing functional assays for DOW's compounds. Cambria...
BioCentury | Jul 26, 2004
Company News

Cambria Biosciences LLC, Syngenta deal

...The companies partnered to develop insecticides. Cambria will use its technologies to identify the mechanisms of...
...mechanisms of action of small molecule compounds from SYNN for insecticides. SYNN will fund research. Cambria...
BioCentury | Nov 4, 2002
Company News

Cambria BioSciences LLC, Dow Chemical deal

...partnered to develop neuroactive insecticides for crop protection and urban pests. Under the three-year deal, Cambria...
...to develop classes of insecticides. Cambria will receive research funding and is eligible for milestones. Cambria...
...an undisclosed number of compounds from DOW’s chemical library for use in developing human therapeutics. Cambria...
BioCentury | Oct 29, 2002
Company News

Cambria, Dow insecticide deal

...partnered to develop neuroactive insecticides for crop protection and urban pests. Under the three-year deal, Cambria...
...to develop classes of insecticides. Cambria will receive research funding and is eligible for milestones. Cambria...
Items per page:
1 - 7 of 7
BioCentury | Jun 11, 2007
Company News

Cambria BioSciences LLC, Pfizer deal

...antiparasitic drug candidates from PFE's Pfizer Animal Health subsidiary. Cambria is eligible for undisclosed milestones. Cambria...
BioCentury | May 18, 2007
Clinical News

Cambria unveils epilepsy program

...Neurology company Cambria (Woburn, Mass.) presented a high throughput in vivo Drosophila model of epilepsy at...
...platform uses fruit flies treated with neurotoxins to screen for compounds that produce anti-epileptic effects. Cambria...
BioCentury | Jan 23, 2007
Financial News

Bionovo raises $15.7 million

...$3.20 on Friday. Investors included RA Capital; Paramount BioCapital; BioCapital Asset Management; and Ironwood Capital. Cambria...
BioCentury | Dec 20, 2004
Company News

Cambria BioSciences LLC, The Dow Chemical Co. deal

...Under a 2002 deal to develop neuroactive insecticides, Cambria received undisclosed milestone payments from DOW subsidiary...
...The milestones were triggered by Cambria validating targets and developing functional assays for DOW's compounds. Cambria...
BioCentury | Jul 26, 2004
Company News

Cambria Biosciences LLC, Syngenta deal

...The companies partnered to develop insecticides. Cambria will use its technologies to identify the mechanisms of...
...mechanisms of action of small molecule compounds from SYNN for insecticides. SYNN will fund research. Cambria...
BioCentury | Nov 4, 2002
Company News

Cambria BioSciences LLC, Dow Chemical deal

...partnered to develop neuroactive insecticides for crop protection and urban pests. Under the three-year deal, Cambria...
...to develop classes of insecticides. Cambria will receive research funding and is eligible for milestones. Cambria...
...an undisclosed number of compounds from DOW’s chemical library for use in developing human therapeutics. Cambria...
BioCentury | Oct 29, 2002
Company News

Cambria, Dow insecticide deal

...partnered to develop neuroactive insecticides for crop protection and urban pests. Under the three-year deal, Cambria...
...to develop classes of insecticides. Cambria will receive research funding and is eligible for milestones. Cambria...
Items per page:
1 - 7 of 7